drugset / Trial / NCT00002531

Combination Chemotherapy in Treating Adults With Acute Lymphocytic Leukemia

NCT00002531 ↗

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells. PURPOSE: Randomized phase II trial to study the effectiveness of various combination chemotherapy regimens in treating patients with acute lymphocytic leukemia.

Timeline

Start
1993-01
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Cyclophosphamide Other / unclassified — Intravenous
Subject Cytarabine Small molecule — Intravenous
Subject Daunorubicin Small molecule — Intravenous
Subject Dexamethasone Small molecule — Oral
Subject Doxorubicin Other / unclassified — Intravenous
Subject Etoposide Small molecule — —
Subject Ifosfamide Small molecule — Intravenous
Subject MERCAPTOPURINE ANHYDROUS Small molecule — Oral
Subject Methotrexate Small molecule — Intravenous
Subject Mitoxantrone Small molecule — Intravenous
Subject Prednisolone Other / unclassified — Oral
Subject Teniposide Small molecule — Intravenous
Subject Thioguanine Small molecule — Oral
Subject Vincristine Small molecule — Intravenous
Subject Vindesine Small molecule — —
Subject asparaginase Protein / enzyme biologic — Intravenous
Background Leucovorin Small molecule — —

Indications